tiprankstipranks
Trending News
More News >
Lonza Group (LZAGY)
OTHER OTC:LZAGY
US Market
Advertisement

Lonza Group (LZAGY) Earnings Dates, Call Summary & Reports

Compare
124 Followers

Earnings Data

Report Date
Jan 28, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.14
Last Year’s EPS
0.96
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 23, 2025|
% Change Since: -6.18%|
Earnings Call Sentiment|Positive
The earnings call reflected strong financial performance and growth across the company's core business areas, particularly in the CDMO segment, leading to upgraded guidance for the fiscal year. However, challenges persist in the Specialized Modalities segment and currency fluctuations posed headwinds. Despite these challenges, the positive achievements and outlook indicate a robust overall sentiment.
Company Guidance -
Q4 2025
During the Half Year Results 2025 Investor and Analyst Conference Call, CEO Wolfgang Wienand announced that One Lonza has achieved a robust performance in the first half of 2025, reporting CHF 3.6 billion in sales, translating into a 19% constant exchange rate (CER) sales growth compared to 2024. This strong performance resulted in a core EBITDA of CHF 1.1 billion, representing a margin growth of 0.4 percentage points to 29.6%. The company also reported a 23.1% sales growth in their core Contract Development and Manufacturing Organization (CDMO) business, excluding Capsules and Health Ingredients (CHI), leading to a core EBITDA margin slightly above 30%. In light of these results and a positive outlook for the second half of the year, Lonza has raised its guidance for the full year 2025, projecting a 20% to 21% CER sales growth and a core EBITDA margin of 30% to 31% for the CDMO business. The CEO attributed these achievements to the dedication and hard work of the company's global workforce, who have maintained performance levels while embracing structural transformations within the company.
Strong Overall Performance
Delivered CHF 3.6 billion in sales with a 19% CER sales growth compared to 2024, resulting in a core EBITDA of CHF 1.1 billion and a margin growth to 29.6%.
CDMO Business Growth
Excluding CHI, CDMO business saw a 23.1% sales growth leading to a core EBITDA margin slightly above 30%.
Upgraded CDMO Outlook
Raised guidance to 20% to 21% CER sales growth and a core EBITDA margin of 30% to 31% for full year 2025.
Integrated Biologics Success
Reported strong CER sales growth of almost 40%, supported by Vacaville acquisition and high demand for assets.
Advanced Synthesis Improvement
Strong CER sales growth of above 18% with a core EBITDA margin of 40.3%, an increase of 6.9 percentage points versus H1 2024.
Capsules and Health Ingredients Recovery
Flat sales growth versus H1 2024 and a core EBITDA margin increase to 26.2%.

Lonza Group (LZAGY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LZAGY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 28, 2026
2025 (Q4)
1.14 / -
0.964
Jul 23, 2025
2025 (Q2)
0.87 / 0.95
0.79818.55% (+0.15)
Jan 29, 2025
2024 (Q4)
0.88 / 0.96
0.72732.60% (+0.24)
Jul 25, 2024
2024 (Q2)
0.56 / 0.80
0.70712.87% (+0.09)
Jan 26, 2024
2023 (Q4)
0.78 / 0.73
0.806-9.80% (-0.08)
Jul 21, 2023
2023 (Q2)
0.90 / 0.71
0.758-6.73% (-0.05)
Jan 25, 2023
2022 (Q4)
0.77 / 0.81
0.61331.48% (+0.19)
Jul 22, 2022
2022 (Q2)
0.74 / 0.76
0.7560.26% (<+0.01)
Jan 26, 2022
2021 (Q4)
0.87 / 0.61
0.72-14.86% (-0.11)
Jul 23, 2021
2021 (Q2)
0.53 / 0.76
0.806-6.20% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

LZAGY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 23, 2025
$69.77$71.88+3.02%
Jan 29, 2025
$65.36$63.59-2.71%
Jul 25, 2024
$58.87$63.35+7.61%
Jan 26, 2024
$42.24$48.57+14.99%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lonza Group (LZAGY) report earnings?
Lonza Group (LZAGY) is schdueled to report earning on Jan 28, 2026, TBA (Confirmed).
    What is Lonza Group (LZAGY) earnings time?
    Lonza Group (LZAGY) earnings time is at Jan 28, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LZAGY EPS forecast?
          LZAGY EPS forecast for the fiscal quarter 2025 (Q4) is 1.14.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis